Login / Signup

Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions.

Robert EvansAlfred KohanRobert MoldwinDaniel RadeckiTill GeibKenneth M Peters
Published in: Neurourology and urodynamics (2021)
These studies did not demonstrate a treatment effect of LiRIS 400 mg compared with placebo, either in patients with IC/BPS with HL, or in those without HL.
Keyphrases
  • double blind
  • spinal cord injury
  • open label
  • clinical trial
  • placebo controlled
  • phase iii
  • smoking cessation